Divalproex Sodium Tablet, Extended Release
NDC 55154-2345
Product Information
Divalproex Sodium is a ANDA-approved product labeled by Cardinal Health 107, Llc. This medication is typically used as a anti-epileptic agent [epc]. It is supplied as a white tablet, extended release for oral administration. This product entry covers the primary NDC 55154-2345 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
AN;757 Code Structure Chart
Product Details
What is NDC 55154-2345?
What are the uses of this product?
What are Active Ingredients of this product?
- DIVALPROEX SODIUM 500 mg/1 - A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- DIVALPROEX SODIUM (UNII: 644VL95AO6)
- VALPROIC ACID (UNII: 614OI1Z5WI) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- AMMONIA (UNII: 5138Q19F1X)
- ETHYL ACRYLATE (UNII: 71E6178C9T)
- METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) (UNII: 74G4R6TH13)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- ISOPROPYL ALCOHOL (UNII: ND2M416302)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- BUTYL ALCOHOL (UNII: 8PJ61P6TS3)
- POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- SHELLAC (UNII: 46N107B71O)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1099569 - divalproex sodium 500 MG 24HR Extended Release Oral Tablet
- RxCUI: 1099569 - 24 HR divalproex sodium 500 MG Extended Release Oral Tablet
- RxCUI: 1099569 - divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.